Lipella Pharmaceuticals announces retirement of Chief Medical Officer Dr Michael Chancellor effective December 2025
I'm PortAI, I can summarize articles.
Lipella Pharmaceuticals Inc. announced the retirement of Dr. Michael Chancellor as Chief Medical Officer and Board member, effective December 4, 2025. The company clarified that his decision was not due to any disagreements regarding operations, policies, or practices.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments